Cosmetic Surgery Market Size To Expand at a Notable CAGR Of 9.81% During 2023 - 2030

Market Research Future (MRFR) has published a cooked research report on the “Global Cosmetic Surgery Market” that contains information from 2018 to 2030. The Cosmetic Surgery market is estimated to register a CAGR of 9.81% during the forecast period of 2023 to 2030.

Market Highlights

The global Cosmetic Surgery market is accounted to register a CAGR of 9.81% during the forecast period and is estimated to reach USD 63.32 billion by 2030.

The cosmetic surgery market refers to the industry that provides surgical procedures and treatments aimed at enhancing or altering a person's physical appearance. It encompasses a wide range of procedures, including breast augmentation, liposuction, rhinoplasty, and facelifts, among others, driven by consumer demand for aesthetic improvements.

Segment Analysis

The global Cosmetic Surgery market has been segmented based on Procedure Type and End User.

On the basis of Procedure Type, the market is segmented into invasive and non-invasive. The invasive segment is further subdivided into procedures including stomach tucks, liposuction, nose jobs, eyelid operations, and breast augmentation. Injections of Botox, soft tissue fillers, chemical peels, laser hair removal, microdermabrasion, dermabrasion, and others are further divided into the non-invasive sector.

Based on End User, the global Cosmetic Surgery market has been segmented into hospitals and dermatology clinics, ambulatory surgical centers, and others. In 2022, the dermatology clinics and hospitals sector dominated the market. The fact that cosmetic surgical procedures are frequently carried out in hospitals, where all supporting infrastructure is available, acts as a motivating element for the industry.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of: Cosmetic Surgery Market Research Report

Key Players:

MRFR recognizes the following companies as the key players in the global Cosmetic Surgery market— AbbVie (US), Cynosure (US), Evolus Inc. (US), Gladerma (Switzerland), REVANCE AESTHETICS (US), Lumenis (Israel), Solta Medical (US), Candela Corporation (US), Alma Laser (Israel), Cutera (US), Sientra, Inc. (US), Fotona (Europe), and Johnson & Johnson Services, Inc. (US).

Regional Analysis

The global Cosmetic Surgery market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Cosmetic Surgery market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Cosmetic Surgery market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Cosmetic Surgery market comprises of Middle East, Africa, and Latin America.

The North America Cosmetic Surgery Market dominated this market in 2022 A large number of procedures are conducted in the area as a result of the well-developed healthcare infrastructure. Aesthetic Plastic Surgery Statistics show that although non-surgical operations rose by 44%, surgical procedures rose by 54%. The average plastic surgeon performed 320 operations in 2021, up from 220 in 2020. Additionally, 365,000 breast augmentations (+44%) were carried out in 2021.  Additionally, 71,000 women had their implants removed but not replaced, compared to 148,000 women who had them removed and replaced (+32% from 2020).

Additionally, the second-largest market share for Cosmetic Surgery is held by Europe. because to improvements in technology, rising healthcare costs, and an increase in the occurrence of skin conditions.

Moreover, From 2023 to 2030, the Asia-Pacific cosmetic surgery market is anticipated to grow at the quickest rate thanks to the backing of nations like China, India, and South Korea. The popularity of cosmetic surgery in South Korea contributes to the expansion of the sector. The Asia-Pacific region's cosmetic surgery industry is expected to develop at the quickest rate in India, with China accounting for the greatest market share.

Key Findings of the Study

• The North America Cosmetic Surgery Market dominated this market in 2022 A large number of procedures are conducted in the area as a result of the well-developed healthcare infrastructure.


• Based on End User, In 2022, the dermatology clinics and hospitals sector dominated the market.


• AbbVie (US), Cynosure (US), Evolus Inc. (US), Gladerma (Switzerland), REVANCE AESTHETICS (US), Lumenis (Israel), Solta Medical (US), Candela Corporation (US), Alma Laser (Israel), Cutera (US), Sientra, Inc. (US), Fotona (Europe), and Johnson & Johnson Services, Inc. (US).